At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 25, 2026 at 19:00 ET
Multiple Teva executives, including the CEO, CFO, and other C-suite officers, exercised stock options and received share grants in a routine compensation-related cluster. EVP Matthew Shields conducted open-market sales totaling $547.7K, representing full disposal of shares acquired through option exercises. All other transactions were non-cash events related to equity compensation.
- EVP Matthew Shields sold 17,295 shares for $547.7K in open-market transactions following option exercises.
- CEO Francis Richard D, CFO Kalif Eliyahu Sharon, and other executives exercised options and received share grants totaling over 300,000 shares, all non-cash events.
- All transactions except Shields' sale were non-cash (codes M, A) and part of standard equity compensation execution.
- Total open-market sales in cluster: $547.7K, representing 0.0015% of Teva's $35.7B market cap, negligible relative to company size.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access